Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1471-1480 of 10940

Edit search filters
  1. PLX038 for the Treatment of Metastatic Ovarian, Peritoneal, and Fallopian Tube Cancers

    Rochester, MN

  2. PET imaging with [18F]BF4

    Rochester, MN

  3. Novel Technique for Cell Cultures in Gynecologic Oncology

    Rochester, MN

  4. Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure

    Jacksonville, FL

  5. A Study to Evaluate Electrical Impedance Myography as an Outcome Measure in Myositis

    Jacksonville, FL

  6. Prospective Use of Real-time MRI

    Rochester, MN

  7. TOCCASTAR - TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

  8. Transcranial Direct Current Stimulation (tDCS) in Children and Adolescents With Epilepsy and Depression

    Rochester, MN

  9. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study of Using Ultrasound to Evaluate Post-Transplant Acute Liver Rejection

    Rochester, MN

.

Mayo Clinic Footer